DigestRedComo funciona
Red
/
Empresas
JC
No verificado

JCR Pharmaceuticals Co., Ltd.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaIndustriaSalud

44 Comunicados de prensa

Ver todos los comunicados de prensa
14/10/2026
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Industria
JCR Pharmaceuticals Receives Marketing Authorization in Kuwait for IZCARGO™, a Blood-Brain Barrier-Penetrating Enzyme Replacement Therapy for Hunter Syndrome
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
02/10/2026
Multimedia
Mercado laboral
Industria
Salud
Biotecnología
Sanidad
Ciencia
Farmacéutica
Italfarmaco and JCR Pharmaceuticals Enter into Exclusive License Agreement for the Development and Potential Commercialization of Novel Investigational Therapy for Hunter Syndrome in the United States, Europe, and Latin America
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
28/09/2026
Industria
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
JCR Pharmaceuticals Receives Orphan Drug Designation from the Ministry of Health, Labour and Welfare of Japan for Givinostat for Duchenne Muscular Dystrophy
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
11/09/2026
Multimedia
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Dose First Patient in Global Phase I/II Trial of JR-446 for Mucopolysaccharidosis Type IIIB
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
21/07/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
JCR Pharmaceuticals Receives Marketing Authorization in the United Arab Emirates for IZCARGO™, a Blood-Brain Barrier-Penetrating Enzyme Replacement Therapy for Hunter Syndrome
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
17/06/2026
Mercado laboral
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
08/06/2026
Ferias y Congresos
Industria
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
JCR Pharmaceuticals’ Research Presentations at the 18th International Symposium on MPS and Related Lysosomal Diseases 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
28/05/2026
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Higiene alimentaria
Medicina - Varios
Eventos
Ferias y Congresos
Industria
JCR Pharmaceuticals to Present at the 18th International Symposium on MPS and Related Lysosomal Diseases 2026
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
18/05/2026
Eventos
Industria
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising Central Nervous System Uptake at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
11/05/2026
Eventos
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
JCR Pharmaceuticals to Present at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0